Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data
Abstract Antibodies targeting the PD-1, PD-L1, and CTLA-4 immune checkpoint axis have been used in a variety of tumor types. They achieve anti-tumor activity through activating the patient’s own immune system to target immune response evading cancer cells. However, this unique mechanism of action ma...
Guardado en:
Autores principales: | Tigran Makunts, Ila M. Saunders, Isaac V. Cohen, Mengxing Li, Talar Moumedjian, Masara A. Issa, Keith Burkhart, Peter Lee, Sandip Pravin Patel, Ruben Abagyan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f9e5c40ece6d4172afc9cd95cfa7fd22 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Publisher Correction: Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
por: Isaac V. Cohen, et al.
Publicado: (2017) -
Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
por: Isaac V. Cohen, et al.
Publicado: (2021) -
Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
por: Isaac V. Cohen, et al.
Publicado: (2017) -
Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes
por: Yuxiao Hu, et al.
Publicado: (2021) -
Viral Myocarditis—From Pathophysiology to Treatment
por: Heinz-Peter Schultheiss, et al.
Publicado: (2021)